Profile
Kate E.
Broderick is Senior Vice President-Research & Development at TriLink BioTechnologies LLC since 2022.
Formerly, Dr. Broderick was Senior Vice President-Research & Development at Inovio Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Broderick was Chief Innovation Officer at Maravai Lifesciences Holdings, Inc. from 2022 to 2025.
Dr. Broderick earned a doctorate from the University of Glasgow.
Kate Broderick active positions
| Companies | Position | Start |
|---|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Former positions of Kate Broderick
| Companies | Position | End |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2025 |
| INOVIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2022 |
Training of Kate Broderick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services Engages in oligonucleotides, modified nucleoside triphosphates, mRNA and long RNA | Commercial Services |
University of Glasgow
University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Maravai Lifesciences Holdings, Inc.
Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
- Stock Market
- Insiders
- Kate Broderick
















